Reply to "Ascertainment of overall survival and the proposed molecular grading tier in IDH-mutant astrocytoma".

Virata MC, Samanamud J, Slocum CC, Kandoi S, Nguyen P, Savani MR, Shi DD, Sharma S, Hiya S, Maldonado-Díaz C, Clare K, Yokoda RT, Vij M, Mir E, Nishikawa Y, Umphlett M, Yong RL, Bederson JB, Silva-Hurtado TJ, Brem S, Hambardzumyan D, Snuderl M, Viapiano MS, Abdullah KG, McBrayer SK, Hatanpaa KJ, Walker JM, Tsankova NM, Richardson TE

Open source

DOI: 10.1093/neuonc/noag211
Published: 2026 Sep 3
Container: Neuro-oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noag211,
  title = {Reply to "Ascertainment of overall survival and the proposed molecular grading tier in IDH-mutant astrocytoma".},
  author = {Virata MC and Samanamud J and Slocum CC and Kandoi S and Nguyen P and Savani MR and Shi DD and Sharma S and Hiya S and Maldonado-Díaz C and Clare K and Yokoda RT and Vij M and Mir E and Nishikawa Y and Umphlett M and Yong RL and Bederson JB and Silva-Hurtado TJ and Brem S and Hambardzumyan D and Snuderl M and Viapiano MS and Abdullah KG and McBrayer SK and Hatanpaa KJ and Walker JM and Tsankova NM and Richardson TE},
  year = {2026},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noag211},
  url = {https://doi.org/10.1093/neuonc/noag211}
}

RIS

TY  - JOUR
TI  - Reply to "Ascertainment of overall survival and the proposed molecular grading tier in IDH-mutant astrocytoma".
AU  - Virata MC
AU  - Samanamud J
AU  - Slocum CC
AU  - Kandoi S
AU  - Nguyen P
AU  - Savani MR
AU  - Shi DD
AU  - Sharma S
AU  - Hiya S
AU  - Maldonado-Díaz C
AU  - Clare K
AU  - Yokoda RT
AU  - Vij M
AU  - Mir E
AU  - Nishikawa Y
AU  - Umphlett M
AU  - Yong RL
AU  - Bederson JB
AU  - Silva-Hurtado TJ
AU  - Brem S
AU  - Hambardzumyan D
AU  - Snuderl M
AU  - Viapiano MS
AU  - Abdullah KG
AU  - McBrayer SK
AU  - Hatanpaa KJ
AU  - Walker JM
AU  - Tsankova NM
AU  - Richardson TE
PY  - 2026
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noag211
UR  - https://doi.org/10.1093/neuonc/noag211
ER  -

APA

MC, V., J, S., CC, S., S, K., P, N., MR, S., DD, S., S, S., S, H., C, M., K, C., RT, Y., M, V., E, M., Y, N., M, U., RL, Y., JB, B., TJ, S., S, B., D, H., M, S., MS, V., KG, A., SK, M., KJ, H., JM, W., NM, T., & TE, R. (2026). Reply to "Ascertainment of overall survival and the proposed molecular grading tier in IDH-mutant astrocytoma".. Neuro-oncology. https://doi.org/10.1093/neuonc/noag211

Source records

pubmed · retrieved 2026-09-26T15:51:40.303Z